
Paul E. Zarek
Examiner (ID: 18450)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1617, 1628, 4161 |
| Total Applications | 773 |
| Issued Applications | 369 |
| Pending Applications | 1 |
| Abandoned Applications | 407 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8140947
[patent_doc_number] => 20120095024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'TOLUIDINE SULFONAMIDES AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/142519
[patent_app_country] => US
[patent_app_date] => 2009-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23890
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20120095024.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142519
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142519 | TOLUIDINE SULFONAMIDES AND THEIR USE | Dec 29, 2009 | Abandoned |
Array
(
[id] => 6314885
[patent_doc_number] => 20100112070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Composition and dosage form comprising a particle formulation and suspending vehicle'
[patent_app_type] => utility
[patent_app_number] => 12/655397
[patent_app_country] => US
[patent_app_date] => 2009-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14889
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112070.pdf
[firstpage_image] =>[orig_patent_app_number] => 12655397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/655397 | Composition and dosage form comprising a particle formulation and suspending vehicle | Dec 28, 2009 | Issued |
Array
(
[id] => 5929859
[patent_doc_number] => 20110039818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'Dosage regimen of an S1P receptor agonist'
[patent_app_type] => utility
[patent_app_number] => 12/655049
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9517
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039818.pdf
[firstpage_image] =>[orig_patent_app_number] => 12655049
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/655049 | Dosage regimen of an S1P receptor agonist | Dec 20, 2009 | Issued |
Array
(
[id] => 7511439
[patent_doc_number] => 20110257149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'FORMULATION FOR ORAL TRANSMUCOSAL ADMINISTRATION OF LIPID-LOWERING DRUGS'
[patent_app_type] => utility
[patent_app_number] => 13/141597
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5992
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257149.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141597
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141597 | Formulation for oral transmucosal administration of lipid-lowering drugs | Dec 16, 2009 | Issued |
Array
(
[id] => 8063581
[patent_doc_number] => 20110245231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCE, AND A METHOD FOR OBTAINING AND THE USE OF SAID ACTIVE SUBSTANCE'
[patent_app_type] => utility
[patent_app_number] => 13/133948
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5352
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245231.pdf
[firstpage_image] =>[orig_patent_app_number] => 13133948
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/133948 | ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCE, AND A METHOD FOR OBTAINING AND THE USE OF SAID ACTIVE SUBSTANCE | Dec 14, 2009 | Abandoned |
Array
(
[id] => 6296254
[patent_doc_number] => 20100160403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'HCV NS3 PROTEASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/638253
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20034
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20100160403.pdf
[firstpage_image] =>[orig_patent_app_number] => 12638253
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/638253 | HCV NS3 PROTEASE INHIBITORS | Dec 14, 2009 | Abandoned |
Array
(
[id] => 7511364
[patent_doc_number] => 20110257074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'METHOD FOR THE PURIFICATION OF SUBSTITUTED CYCLOPENT-2-EN-1-ONE CONGENERS AND SUBSTITUTED 1,3-CYCLOPENTADIONE CONGENERS FROM A COMPLEX MIXTURE USING COUNTERCURRENT SEPARATION'
[patent_app_type] => utility
[patent_app_number] => 12/634877
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 26749
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257074.pdf
[firstpage_image] =>[orig_patent_app_number] => 12634877
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/634877 | METHOD FOR THE PURIFICATION OF SUBSTITUTED CYCLOPENT-2-EN-1-ONE CONGENERS AND SUBSTITUTED 1,3-CYCLOPENTADIONE CONGENERS FROM A COMPLEX MIXTURE USING COUNTERCURRENT SEPARATION | Dec 9, 2009 | Abandoned |
Array
(
[id] => 7587431
[patent_doc_number] => 20110281941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'COMBINATION OF LYCOPENE, POLYPHENOL, AND VITAMINS FOR THE CARE OF KERATIN MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 13/132539
[patent_app_country] => US
[patent_app_date] => 2009-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10870
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281941.pdf
[firstpage_image] =>[orig_patent_app_number] => 13132539
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132539 | Combination of lycopene, polyphenol, and vitamins for the care of keratin materials | Dec 2, 2009 | Issued |
Array
(
[id] => 5937472
[patent_doc_number] => 20110212931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'ANTIOXIDANT'
[patent_app_type] => utility
[patent_app_number] => 13/127698
[patent_app_country] => US
[patent_app_date] => 2009-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12116
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212931.pdf
[firstpage_image] =>[orig_patent_app_number] => 13127698
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127698 | Antioxidant | Nov 17, 2009 | Issued |
Array
(
[id] => 6055708
[patent_doc_number] => 20110112068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/615903
[patent_app_country] => US
[patent_app_date] => 2009-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 31289
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112068.pdf
[firstpage_image] =>[orig_patent_app_number] => 12615903
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/615903 | Human immunodeficiency virus protease inhibitors | Nov 9, 2009 | Issued |
Array
(
[id] => 6314697
[patent_doc_number] => 20100112035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'MULTIPLE COMPONENT FOOD PRODUCT USEFUL FOR DELIVERING GLUCOSAMINE AND/OR N-ACETYL-D-GLUCOSAMINE'
[patent_app_type] => utility
[patent_app_number] => 12/613386
[patent_app_country] => US
[patent_app_date] => 2009-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7970
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112035.pdf
[firstpage_image] =>[orig_patent_app_number] => 12613386
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/613386 | MULTIPLE COMPONENT FOOD PRODUCT USEFUL FOR DELIVERING GLUCOSAMINE AND/OR N-ACETYL-D-GLUCOSAMINE | Nov 4, 2009 | Abandoned |
Array
(
[id] => 7696093
[patent_doc_number] => 20110230497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'BIOLOGICALLY ACTIVE AMIDES'
[patent_app_type] => utility
[patent_app_number] => 13/127099
[patent_app_country] => US
[patent_app_date] => 2009-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28600
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230497.pdf
[firstpage_image] =>[orig_patent_app_number] => 13127099
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127099 | BIOLOGICALLY ACTIVE AMIDES | Nov 1, 2009 | Abandoned |
Array
(
[id] => 7685232
[patent_doc_number] => 20100120909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'COMPOSITION BASED ON SUBSTITUTED 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES, PREPARATION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/609270
[patent_app_country] => US
[patent_app_date] => 2009-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 19689
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120909.pdf
[firstpage_image] =>[orig_patent_app_number] => 12609270
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/609270 | Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof | Oct 29, 2009 | Issued |
Array
(
[id] => 6320686
[patent_doc_number] => 20100113417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Substituted Spiroamine Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/608543
[patent_app_country] => US
[patent_app_date] => 2009-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30665
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113417.pdf
[firstpage_image] =>[orig_patent_app_number] => 12608543
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/608543 | Substituted spiroamine compounds | Oct 28, 2009 | Issued |
Array
(
[id] => 5987309
[patent_doc_number] => 20110098326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => '2-FLUOROTHIAZOLE DERIVATIVES USEFUL AS IMAGING AGENTS; METHODS OF SYNTHESIS, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/605467
[patent_app_country] => US
[patent_app_date] => 2009-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7328
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098326.pdf
[firstpage_image] =>[orig_patent_app_number] => 12605467
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/605467 | 2-FLUOROTHIAZOLE DERIVATIVES USEFUL AS IMAGING AGENTS; METHODS OF SYNTHESIS, AND METHODS OF USE | Oct 25, 2009 | Abandoned |
Array
(
[id] => 9389408
[patent_doc_number] => 08686006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Pharmaceutical composition for improving intestinal absorption'
[patent_app_type] => utility
[patent_app_number] => 13/124797
[patent_app_country] => US
[patent_app_date] => 2009-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9283
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124797
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124797 | Pharmaceutical composition for improving intestinal absorption | Oct 21, 2009 | Issued |
Array
(
[id] => 6616892
[patent_doc_number] => 20100099741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Molecular Targets for Treatment of Learning and Memory Dysfunction'
[patent_app_type] => utility
[patent_app_number] => 12/582547
[patent_app_country] => US
[patent_app_date] => 2009-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17619
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099741.pdf
[firstpage_image] =>[orig_patent_app_number] => 12582547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/582547 | Molecular Targets for Treatment of Learning and Memory Dysfunction | Oct 19, 2009 | Abandoned |
Array
(
[id] => 6128231
[patent_doc_number] => 20110086911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'NOVEL BISMUTH(III) NSAID COMPOUNDS AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 12/578118
[patent_app_country] => US
[patent_app_date] => 2009-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10589
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086911.pdf
[firstpage_image] =>[orig_patent_app_number] => 12578118
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/578118 | NOVEL BISMUTH(III) NSAID COMPOUNDS AND METHODS FOR THEIR USE | Oct 12, 2009 | Abandoned |
Array
(
[id] => 6360651
[patent_doc_number] => 20100087519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'USE OF EQUOL FOR TREATING ANDROGEN MEDIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/572791
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 17525
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087519.pdf
[firstpage_image] =>[orig_patent_app_number] => 12572791
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/572791 | Use of equol for treating androgen mediated diseases | Oct 1, 2009 | Issued |
Array
(
[id] => 7696023
[patent_doc_number] => 20110230567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'VINYL ALCOHOL CO-POLYMER CRYOGELS, VINYL ALCOHOL CO-POLYMERS, AND METHODS AND PRODUCTS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/998077
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10762
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230567.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998077
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998077 | Vinyl alcohol co-polymer cryogels, vinyl alcohol co-polymers, and methods and products thereof | Sep 13, 2009 | Issued |